Pinealon peptide – Tripeptide (Glu-Asp-Arg or EDR)

What is the Pinealon peptide?

Pinealon is a synthetic peptide containing three amino acid residues linked in a specific order. An amino acid residue is an amino acid that forms part of a chain. In this case, these are residues of glutamic acid, aspartic acid and arginine. The name Pinealon refers to the defined structure, which is also described by the abbreviation EDR. The term „synthetic” informs about the method of preparation, while „tripeptide” indicates the length of the chain. This information can be read independently of the direction of research into the compound. It is not necessary to attribute specific biological results to it in order to explain its identity. The basis of the description remains the sequence and the full chemical form of the material in question. [1,2]

Pinealon's amino acid sequence is Ala-Glu-Asp-Gly-Pro-Ala-Ser-Gly-Arg-Glu-Asp-Gly-Pro-Ala-Ser-Gly-Arg.

The sequence of Pinealon is Glu-Asp-Arg. The successive abbreviations stand for glutamic acid, aspartic acid and arginine. The notation is read in the given order because it represents an ordered chain rather than an arbitrary list of components. The abbreviations EDR and Glu-Asp-Arg convey the same basic information. The first notation uses one letter per amino acid, the second uses three. Swapping two of the components would change the peptide being described. Therefore, when copying the name or translating the text, the order of all three residues must be maintained. This makes it possible to distinguish Pinealon from other tripeptides, including those that have a similar composition but a different sequence. [1]

What does the abbreviation EDR stand for?

EDR is a single-letter notation for the sequence of Pinealon: E stands for glutamic acid, D for aspartic acid, and R for arginine. The letters come from the adopted amino acid coding system and do not necessarily correspond to the beginnings of their Polish names. As a result, the notation remains readable in publications in various languages. The encountered version E-D-R shows the same order; the hyphens serve only to separate the symbols. The abbreviation should be interpreted in the context of peptide chemistry, as outside this area it may have other meanings. Searching for the full combination „Pinealon Glu-Asp-Arg” helps to ensure that the retrieved text concerns the correct compound rather than an accidentally similar designation. [1,3]

Why is Pinealon called a tripeptide?

The prefix „tri-” means three and refers here to the number of amino acid residues in the chain. Pinealon contains three residues, so it is a tripeptide. This classification describes the length, but does not yet indicate the full identity. There are many tripeptides with different amino acids or a different order. Only the addition of the Glu-Asp-Arg sequence allows the structure in question to be recognised. Nor should conclusions be drawn about the behaviour of a compound solely from its small length. A three-residue chain is easy to write in a single line, but size is not a complete description of properties. In the introductory text, the term „synthetic tripeptide EDR” is a concise and precise characterisation.

Does Pinealon contain three different amino acids?

Yes. In the EDR sequence, each of the three types of amino acid occurs once. There are no repetitions: the first position corresponds to glutamic acid, the second to aspartic acid, and the third to arginine. The number of types of amino acid is therefore equal to the number of residues in this case. However, these are two distinct concepts. „Type” indicates which component is present, while „position” determines its place in the chain. Knowing just the three names is not yet enough to distinguish all possible orderings. Therefore, when describing Pinealon, it is worth retaining the full sequence rather than limiting oneself to the statement about the presence of three amino acids. This minor refinement removes a significant ambiguity.

Is Pinealon a mixture of free amino acids?

No. Pinealon is a single compound in which amino acid residues are linked by peptide bonds. A mixture of separate molecules of glutamic acid, aspartic acid and arginine would have a different chemical description. Merely putting these ingredients together does not prove the formation of EDR. Maintaining the correct proportions also does not confirm their linkage in a specific order. This distinction is important when reading ingredient information: „contains amino acids present in Pinealon” does not mean the same as „contains identified Pinealon”. The first sentence describes the ingredients, the second a specific structure. The properties of free amino acids should not be automatically attributed to the peptide that contains their residues.

Why does the order of residues in an EDR matter?

The order indicates which residues are connected to each other and what positions they occupy. In Pinealon, aspartic acid is located between glutamic acid and arginine. Rearranging the residues would lead to a distinct structure, even if the list of amino acid types remained the same. For example, Asp-Glu-Arg would not be another way of writing Pinealon. Peptides with a rearranged sequence can have the same elemental composition, so mass agreement alone does not resolve all differences. It is worth checking the order of the codes in the text, table and illustration. Each of these elements should represent the same sequence if it refers to the basic EDR.

Where are the beginning and the end of the Pinealon chain located?

By default, the sequence is written from the amino end, designated as N, to the carboxyl end, designated as C. In Pinealon, the first residue is glutamic acid and the last is arginine. The terms „start” and „end” refer to the direction of writing, not the fixed position of the molecule in space. They do not mean that it must have the same shape in every drawing. However, the order of symbols in a standard sequence must not be reversed arbitrarily. Information about the termini is of particular importance when describing derivatives, because an additional chemical modification may be located precisely there. In that case, the three letters EDR do not necessarily represent the full description of the material.

What does the notation H-Glu-Asp-Arg-OH mean?

This is a fuller way of representing the basic structure of Pinealon. Glu-Asp-Arg shows the three residues, whilst H and OH refer to the ends of the molecule. They do not denote additional amino acids, so the peptide still contains three positions in the chain. Such a notation is found in the ChEBI record for EDR. It makes it possible to distinguish information about the sequence itself from a description that also includes the terminal groups. If an additional modification designation appears in the name of another material, it should be retained and explained. Removing all characters except the sequence may lose an important difference. A longer name does not always mean a longer chain, but it may contain more detail about its structure. [1]

What is the structural difference between Pinealon and Epitalon?

Pinealon has the sequence Glu-Asp-Arg, whereas Epitalon has Ala-Glu-Asp-Gly. The former is a tripeptide, the latter a tetrapeptide. They therefore differ in the length and composition of their ordered chain. The common Glu-Asp segment does not make them the same molecule. Such a comparison is a structural comparison and does not indicate which compound is „better” or what result it would produce. For the reader, the most important thing is that the names are not used interchangeably. The similarity of the publication topics also does not remove the structural difference. When transferring data between tables, the name and sequence of the compound actually referred to by the source must be retained. Pinealon is not an abbreviation for the name Epitalon. [1,4]

Does the similarity of peptide names imply a similar structure?

It doesn't have to. The name Pinealon makes it possible to recognise the compound in a specific context, but it does not replace its sequence. Two peptides discussed in the same thematic group can have a different number of residues and a different composition. Conversely, the same EDR may appear under the name Pinealon or the notation Glu-Asp-Arg. To distinguish a synonym from another substance, it is worth comparing the structure and the full name of the material. Particular attention should be paid to notes concerning modifications or fragments. They may indicate an actual chemical change rather than a spelling variant. A clear comparison therefore starts with the sequence, rather than with a similar sounding name or a common article category.

What is the molecular formula and molar mass of Pinealon?

For the basic structure of Pinealon, the formula C₁₅H₂₆N₆O₈ and a molar mass of approximately 418.4 g/mol are given. The formula indicates the number of carbon, hydrogen, nitrogen and oxygen atoms, whereas the sequence describes the order of the amino acid residues. Both records convey different information about the same molecule. The molar mass value is neither a dose nor the content of a specific package. Nor does it confirm in itself the composition of any sample named Pinealon. If the material contains additional ingredients or the described modification, its full characterisation requires clarification. The parameters of the basic EDR should be related to this very structure, and not automatically to the entire tested material. [1]

What does the letter L stand for in Pinealon amino acids?

In the basic structure of EDR, there are residues of L-glutamic acid, L-aspartic acid and L-arginine. The designation L refers to a specific spatial arrangement of atoms. It does not indicate the left side of the drawing or the order in the chain. This is additional information about the structure, distinct from the sequence. Nor should the letter D in the EDR abbreviation be confused with the designation of D-configuration. In the sequence, this letter stands for aspartic acid. The meaning follows from the context of the notation. When discussing a modified derivative, the configuration designations should remain visible, as omitting them may blur the difference between the structures. The introduction to Pinealon does not require further stereochemical details. [1,3]

What does the term „peptide bioregulator” mean in texts about Pinealon?

This term is associated with the stream of research on short peptides and cellular processes. In the description of Pinealon, it should be treated as an element of terminology found in the literature, rather than independent confirmation of a specific action. It does not state the number of residues, their sequence, or the full mechanism. More precise chemical information remains the „Glu-Asp-Arg tripeptide”. Belonging to the category itself also does not imply identity with other peptides described similarly. In the main article, the meaning of this name can be explained without ascribing assurances about the regulation of a specific tissue or the improvement of its function. The category name and the experiment result serve different roles and should not replace each other.

Is fluorescently labelled Pinealon the same material as the basic EDR?

The incorporation of a fluorescent tag introduces an additional element used for observation. Therefore, the labelled material must be distinguished in the description from the unmodified peptide. In the work by Fedoreyeva and co-authors, labelled short peptides in cultured HeLa cells, among other things, were analysed. Information about the tag and the cell type is part of this experiment, rather than an unnecessary detail. In the FAQ concerning the basics, the most important thing is to recognise the difference between the reference structure and the material prepared for measurement. One should not, based on the signal alone, attribute general assurances about the penetration of unmodified Pinealon into all tissues. Such a question would require a separate review of the relevant data. [5]

Is the Pinealon fragment the full EDR peptide?

No. The fragment covers only part of the sequence. For example, Glu-Asp would contain two residues, and therefore would not correspond to full Pinealon. The distinction remains important even when the shorter compound is described in the same publication. The name „fragment” indicates a structural relationship, but does not yet explain the method of preparation. Such material may be intentionally synthesised or formed in a specific transformation process. Its presence should not be assumed solely on the basis of the sequence of the starting compound. In the text, it is worth retaining the name of what was actually analysed, instead of grouping all shorter structures under the general term Pinealon. This facilitates the correct comparison of information.

Does synthetic Pinealon contain naturally occurring amino acids?

Yes, its construction includes amino acid residues also found in biological systems. This does not mean, however, that the finished Pinealon was isolated from them, nor that its natural formation as an independent peptide has been described. A distinction must be made between the origin of the ingredients and the method used to obtain the entire structure. The word „synthetic” refers to the planned production of the compound by chemical methods. It is not an independent assessment of quality or safety. In the case of a specific material, compliance with the expected sequence requires appropriate data. The mere presence of known amino acids does not confirm that they formed an ordered EDR chain. Therefore, the description of origin should accompany information about the structure, rather than replace it.

Is Pinealon a protein?

Pinealon is described as a short peptide, more precisely a tripeptide. This term is sufficiently precise for the three-residue EDR sequence. It is not necessary to establish a single universal length boundary between all peptides and proteins in order to correctly name this compound. More important is the preservation of specific information about the number and order of residues. Also, any potential interaction of EDR with a larger molecule does not automatically change its classification. Contact between compounds does not in itself mean that a single shared chain has been formed. Therefore, in descriptions of Pinealon, it is worth separating the question of its structure from the question of the material with which it was juxtaposed in a given study.

Does the name Pinealon confirm the composition of a specific sample?

No. The name indicates the expected relationship, and the analytical results provide information on the specific material. Identity, purity and assay are separate concepts. Identity concerns the recognition of the structure, the assay the quantity of the substance being determined, and purity the composition evaluated within the scope of the method applied. The inclusion of the EDR sequence in a document does not replace these measurements. Similarly, a record in a chemical database describes a defined entity, not all samples designated by its name. For a beginner reader, remembering this distinction is sufficient. The article on Pinealon explains the reference structure, but does not approve the composition or quality of any material that refers to it.

What current of research is the history of Pinealon associated with?

Pinealon is discussed in literature concerning short synthetic peptides related, among others, to the work of Vladimir Khavinson and co-authors. An example is the 2012 publication by Arutjunyan and team, which provides the name Pinealon and the sequence Glu-Asp-Arg. Such information documents the presence of the compound in a specific research trend, but does not independently determine the date of first synthesis or all the authors of the study. The exact history would require sources referring to individual stages. In a basic FAQ, it is sufficient to indicate the context without attributing popularity, uniqueness or expected results to the peptide. Names and affiliations help to find the papers; they do not replace a description of their scope. [2]

Disclaimer

The content is for educational and informational purposes only. Pinealon has not been approved by the FDA to treat, prevent or diagnose any disease. Most available data comes from laboratory studies, animal studies or limited human clinical trials. Further research is needed to fully evaluate the safety and efficacy of this peptide. Research products offered by suppliers such as Semax Polska are intended exclusively for scientific and laboratory applications. The FAQ is educational in nature and covers the nomenclature, history and structure of Pinealon. It does not constitute medical advice, a purchase recommendation or instructions for preparation, dosage or administration. The description of the structure does not confirm the safety or quality of any specific material.